The objective of this study was to establish the current periorbital cellulitis management strategies in the United Kingdom (UK) through analysis of the prevalence of guidelines and comparison against evidence-based management.
| ME TH ODS
Ethical consideration concluded that this study was a service evaluation project.
Fifty-one acute admitting otolaryngology units were selected from each regional Health Education Authority across the UK, with a minimum of 2 per Health Education Authority and contacted via telephone by AO. Units in each HEA were split into tertiary and non-tertiary centres and arranged in alphabetical order. First on-call otolaryngologists were contacted at each unit in alphabetical order, if unreachable the next unit on the list was contacted. A tertiary and non-tertiary care centre were contacted in each HEA.
| RESULTS

| Demographics
First on-call Otolaryngology doctors of various grades ( Figure 1) were contacted from 51 acute admitting units in the UK; 27 tertiary referral units and 24 secondary referral units by telephone (Figure 2) .
Twenty-three trusts of 51 (45.1%) were confirmed as having 24 guidelines (one unit had separate adult and paediatric guidance) for the treatment of periorbital cellulitis. Eighteen of the 24 (75%) guidelines found were obtained from 17 trusts for analysis.
Three additional microbiology guidelines for the treatment of periorbital cellulitis were obtained from three separate healthcare trusts.
| Laboratory investigations (from 18 guidelines)
Six (33.3%) guidelines did not specify any laboratory investigations.
All other 12 (66.7%) guidelines specified a full blood count and Creactive protein level, 4 (22.2%) asked for urea and electrolytes levels, 1 (5.6%) specified an erythrocyte sedimentation rate and 1 (5.6%) a serum lactate level.
| Microbiology
Three (16.7%) guidelines did not specify any microbiological investigations. All remaining 15 (83.3%) guidelines specified a blood culture to be taken from patients; however, one of which only if the patient was pyrexial. Seven (38.9%) guidelines required eye swabs 
| Medical adjuncts
Nine (50%) guidelines suggested the use of medical adjuncts. Three (16.7%) of the guidelines specified the use of xylometazoline hydrochloride (Otrivine) nasal spray, 3 (16.7%) also specified topical ephedrine, 1 (5.6%) oral pseudoephedrine (Sudafed), 1 specified phenylephrine nasal drops, 1 (5.6%) beclomethasone nasal spray (Beconase) and 2 (11.1%) guidelines asked for the use of nasal decongestants but did not specify the drug or the route of administration. Six (33.3%) guidelines did not specify the frequency or extent of cross-specialty review. Nine (50%) guidelines studied required Ophthalmology and Otolaryngology review for all patients admitted with suspected periorbital cellulitis. One (5.6%) specified only Otolaryngology review and two (11.1%) specified only ophthalmology review.
| Surgery
Ten (55.6%) of the guidelines examined did not specify surgical indications for patients with suspected periorbital cellulitis. One (5.6%) guideline specified rapidly deteriorating vision as an indication for surgery; 4 (22.2%) use radiological evidence of a periorbital abscess; and two (11.1%) clinical suspicion of periorbital abscess as indications for surgery.
| DISCUSSION
| Clinical applicability
The most striking observation from this snapshot of orbital cellulitis guidance was that less than half (45.1%) of units contacted had formal guidance readily available for first on-call otolaryngologists for an emergency that has sight and potentially life-threatening complications. 72.5% of on-call doctors contacted were foundation doctors, core trainees or GP trainees, therefore, likely inexperienced at assessment of a relatively infrequent but serious pathology.
The most frequent complications of periorbital cellulitis are visual and therefore specialist review by an Ophthalmologist should always be sought. However, only 61.1% of guidelines specified ophthalmology review for patients admitted with periorbital cellulitis, a sightthreatening infection. Furthermore, frequency of review was often not specified.
Imaging in periorbital cellulitis should occur if there is suspicion of a subperiosteal, orbital or intracranial abscess. Clinical signs that may indicate the above are specified in 72.2% of guidelines and include but are not limited to: no clinical improvement after 24-48 hours of best medical therapy, eye signs, inability to assess the eye, or central nervous system signs. Predictive accuracy of subperiosteal or orbital abscess by clinical judgment alone is 82%, this increases to 91% after contrast CT, with MRI a useful tool in cases of diagnostic uncertainty or a suspicion of intracranial complications. 4 Less than a quarter (22.2%) of guidelines specified contrast CT orbit and paranasal sinuses (half of these also included any 
| Limitations
The ability to find appropriate protocols is user dependent, therefore protocols might exist in some units that first on-call otolaryngologists were unable to locate. However, if this is the case, it reflects the dilemmas junior clinicians face. Six (25%) protocols were not obtained, the contents of these are unknown and may have contributed to a differing view of our results.
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